In leukaemia, mutant Kit participates in the PI3K-Akt pathway, in STAT5 activation, in the RhoA-Rho kinase pathway47 and in activation of Src-like adaptor protein60, and there is great interest in further understanding the spatial organization of this signalling. Here, AKT1 is linked to leukemia.